Day One Biopharmaceuticals Inc - DAWN - stock price prediction, stock price target, analyst ratings from 10 analysts
Day One Biopharmaceuticals Inc has a share price target of US$ 33, revenue growth forecast of 25.1%, and profit growth estimate of -43.1% for FY25, based on top 10 analyst calls.